Back
Day Range
$81.86
$83.79
52-Week Range
$65.94
$87.89
Volume
3,255,941
50D / 200D Avg
$82.43
/
$80.42
Prev Close
$82.50
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 44.4 | 0.4 |
| P/B | 4.6 | 2.9 |
| ROE % | 10.6 | 3.8 |
| Net Margin % | 17.7 | 3.9 |
| Rev Growth 5Y % | 3.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$96.38
+17.5%
Low: $87.00
High: $110.00
Forward P/E
27.6
Forward EPS
$2.97
EPS Growth (est.)
+0.0%
Est. Revenue
6.7 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$4.56
$4.47 – $4.63
|
9.7 B | 2 |
| FY2029 |
$4.20
$4.12 – $4.27
|
8.9 B | 2 |
| FY2028 |
$3.73
$3.54 – $3.92
|
8.1 B | 4 |
Key Takeaways
Revenue grew 3.77% annually over 5 years — modest growth
Earnings declined -74.28% over the past year
ROE of 10.56% — decent returns on equity
Net margin of 17.69% shows strong profitability
Debt/Equity of 0.07 — conservative balance sheet
Generating 1.34B in free cash flow
Growth
Revenue Growth (5Y)
3.77%
Revenue (1Y)11.55%
Earnings (1Y)-74.28%
FCF Growth (3Y)45.63%
Quality
Return on Equity
10.56%
ROIC11.11%
Net Margin17.69%
Op. Margin26.97%
Safety
Debt / Equity
0.07
Current Ratio3.72
Interest Coverage0.00
Valuation
P/E Ratio
44.38
P/B Ratio4.61
EV/EBITDA27.75
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.55% | Revenue Growth (3Y) | 10.05% |
| Earnings Growth (1Y) | -74.28% | Earnings Growth (3Y) | -12.51% |
| Revenue Growth (5Y) | 3.77% | Earnings Growth (5Y) | -8.07% |
| Profitability | |||
| Revenue (TTM) | 6.07B | Net Income (TTM) | 1.07B |
| ROE | 10.56% | ROA | 7.84% |
| Gross Margin | 78.13% | Operating Margin | 26.97% |
| Net Margin | 17.69% | Free Cash Flow (TTM) | 1.34B |
| ROIC | 11.11% | FCF Growth (3Y) | 45.63% |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 3.72 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 44.38 | P/B Ratio | 4.61 |
| P/S Ratio | 7.85 | PEG Ratio | -0.63 |
| EV/EBITDA | 27.75 | Dividend Yield | 0.00% |
| Market Cap | 47.64B | Enterprise Value | 45.40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.07B | 5.44B | 5.01B | 5.38B | 5.23B |
| Net Income | 1.07B | 4.17B | 1.40B | 1.52B | 1.50B |
| EPS (Diluted) | 1.83 | 6.97 | 2.30 | 2.44 | 2.38 |
| Gross Profit | 4.74B | 4.32B | 3.97B | 4.22B | 4.01B |
| Operating Income | 1.64B | 1.38B | 1.43B | 1.70B | 1.61B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13.70B | 13.06B | 9.36B | 8.29B | 8.50B |
| Total Liabilities | 3.36B | 2.99B | 2.64B | 2.49B | 2.67B |
| Shareholders' Equity | 10.34B | 10.00B | 6.65B | 5.81B | 5.84B |
| Total Debt | 705.40M | 700.00M | 685.10M | 691.30M | 690.30M |
| Cash & Equivalents | 2.94B | 3.05B | 1.13B | 769.00M | 862.80M |
| Current Assets | 6.74B | 6.29B | 4.04B | 3.10B | 3.18B |
| Current Liabilities | 1.81B | 1.51B | 1.20B | 1.02B | 1.03B |